Flag of the European Union EU Clinical Trials Register Help

Clinical trials for IND

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    1,080 result(s) found for: IND. Displaying page 1 of 54.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2009-010404-28 Sponsor Protocol Number: G83627057 Start Date*: 2009-06-12
    Sponsor Name:Fundación de Investigación Biomédica del Hospital Universitario La Paz, Madrid
    Full Title: PREVENCIÓN DEL SÍNDROME DE BAJO GASTO POSTOPERATORIO EN RECIÉN NACIDOS SOMETIDOS A CIRUGÍA CARDIOVASCULAR: ESTUDIO PILOTO SOBRE LA FARMACOCINÉTICA Y FARMACODINAMIA DOSIS-DEPENDIENTE DE DOS INODILA...
    Medical condition: Este estudio evaluará la eficacia de dos inodilatadores (IND) en el tratamiento del síndrome de bajo gasto postoperatorio (SBGP) en recién nacidos sometidos a cirugía cardiovascular (CCV)
    Disease: Version SOC Term Classification Code Term Level
    9 10024899 Low cardiac output syndrome LLT
    9 10010495 Congenital heart disease NOS LLT
    Population Age: Newborns, Under 18 Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-004316-18 Sponsor Protocol Number: 2006-05 Start Date*: 2017-11-21
    Sponsor Name:Jazz Pharmaceuticals
    Full Title: Defibrotide for Patients with Hepatic Veno-occlusive Disease (VOD): A Treatment IND Study
    Medical condition: Hepatic Veno-Occlusive Disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004871 10047207 Veno-occlusive liver damage LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2011-000563-28 Sponsor Protocol Number: HLS01/2011 Start Date*: 2012-06-25
    Sponsor Name:AZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)
    Full Title: Randomized prospectic clinical trial for delivery induction in patients with unfavoreable obstetric conditions.
    Medical condition: Delivery induction in patients with unfavoreable obstetrical conditions.
    Disease: Version SOC Term Classification Code Term Level
    14.0 10042613 - Surgical and medical procedures 10052856 Labour induction PT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-006133-32 Sponsor Protocol Number: P04685 Start Date*: 2006-09-20
    Sponsor Name:Allergie-Centrum-Charité
    Full Title: An exploratory phase IV, randomised, double-blind, placebo controlled crossover study to assess and compare the effects of 5 mg vs. 20 mg Desloratadine on the development of experimentally induced ...
    Medical condition: Acquired cold urticaria (ACU) is a frequent form of physical urticaria that is characterized by the development of wheal and flare type skin reactions after cold exposure.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10046741 Urticaria cold LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-005786-35 Sponsor Protocol Number: DC02RUP/IV/02 Start Date*: Information not available in EudraCT
    Sponsor Name:Uriach Pharma
    Full Title: Proof-of-concept, cross over, double blind, placebo-controlled study to assess if Rupatadine 20 mg can improve critical stimulation time thresholds (CSTTs) in patients with acquired cold urticaria
    Medical condition: Acquired Cold Urticaria
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009869 Cold urticaria LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-002061-29 Sponsor Protocol Number: 08227 Start Date*: 2016-03-21
    Sponsor Name:Consorci Sanitari de Terrassa
    Full Title: Prospective randomized clinical trial comparing the effect of vaginal misoprostol synchronously with supracervical ball, versus only vaginal misoprostol for induction of labor.
    Medical condition: Pegnant women with a term singleton pregnancy, cephalic presentation, reassuring fetal heart rate pattern, intact membranes and an unfavorable cervix (Bishop score less than 6), admitted to our ins...
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004865 10055563 Labor induction LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-003098-88 Sponsor Protocol Number: PED/VITD/1 Start Date*: 2014-02-26
    Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar) [...]
    1. Consorci Mar Parc de Salut de Barcelona (Parc de Salut Mar)
    2. Kern Pharma, S.L.
    Full Title: An open, controlled, double-blind, with placebo clinical trial and randomized in subgroups of pediatric patients with allergic and non-allergic asthma, with deficiency, insufficiency or normal leve...
    Medical condition: One hundred and sixty children with allergic or non-allergic asthma, deficit, insufficiency or normal levels of Vitamin D.
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-000206-18 Sponsor Protocol Number: PM1183-B-005-14-QT Start Date*: 2015-09-10
    Sponsor Name:PharmaMar S.A., Sociedad Unipersonal
    Full Title: Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization (QTc Duration) in Patients with Selected Solid Tumors
    Medical condition: - small cell lung cancer (SCLC) - head and neck carcinoma (H&N) - neuroendocrine tumors (NETs) - biliary tract carcinoma - endometrial carcinoma - BRCA 1/2-associated metastatic breast carcinoma - ...
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004864 10048683 Advanced cancer LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2008-005746-22 Sponsor Protocol Number: AECUDATT Start Date*: 2009-05-05
    Sponsor Name:Allergie-Centrum-Charite, Department of Dermatology, Charite - Universitätsmedizin Berlin
    Full Title: Multi-center, double blind, dose escalating study to compare the effects of 5 mg, 10mg and 20mg of Desloratadine in patients with acquired cold urticaria (ACU)
    Medical condition: Chronic urticaria is characterized by the spontaneous development of wheal and flare type skin reactions.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009869 Cold urticaria LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-004940-29 Sponsor Protocol Number: SANNARU486 Start Date*: 2005-01-13
    Sponsor Name:AZIENDA SANITARIA OSPEDALIERA O.I.R.M. - S. ANNA
    Full Title: VOLUNTARY TERMINATION OF PREGNANCY WITH MIFEPRISTONE RU486 AND MISOPROSTOL
    Medical condition: VOLUNTARY TERMINATION OF PREGNANCY LAW N.194/1978
    Disease: Version SOC Term Classification Code Term Level
    6.1 10000220 PT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-000776-34 Sponsor Protocol Number: DFNS01 Start Date*: 2011-06-07
    Sponsor Name:Umea University
    Full Title: THE EFFECT OF DIFLUNISAL ON FAMILIAL TRANSTHYRETIN AMYLOIDOSIS: An open label extension study of ”the diflunisal trial” (IND 68092), and an open label observational study on previously untreated p...
    Medical condition: Familial transthyretin amyloidosis
    Disease: Version SOC Term Classification Code Term Level
    13.1 10010331 - Congenital, familial and genetic disorders 10019893 Hereditary neuropathic amyloidosis, Swedish type LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2005-004984-43 Sponsor Protocol Number: MONTEIA Start Date*: 2005-11-14
    Sponsor Name:UNIVERSITA DEGLI STUDI DI UDINE
    Full Title: Randomized, double-blind, placebo controlled trial on the efficacy of montelukast in exercise-induced asthma in children
    Medical condition: exercise-induced asthma
    Disease: Version SOC Term Classification Code Term Level
    6.1 10003557 PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-005007-33 Sponsor Protocol Number: BIBEC02 Start Date*: 2012-02-17
    Sponsor Name:Laboratorios Biomendi S.A.U.
    Full Title: A multicenter, randomized, double-blind, parallel groups, placebo-controlled trial to evaluate efficacy and safety of a new i.v. formulation of ibuprofen 800 mg every 6 hours in the management of p...
    Medical condition: Moderate to severe postoperative pain.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10022117 - Injury, poisoning and procedural complications 10054711 Postoperative pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2005-000194-21 Sponsor Protocol Number: 150/04 Start Date*: 2004-12-31
    Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA
    Full Title: Effetti della L-argina nella profilassi della ipertensione cronica dal secondo trimestre di gravidanza
    Medical condition: Profilassi della ipertensione cronica dal secondo trimestre di gravidanza
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036563 Pregnancy induced hypertension LLT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-003746-41 Sponsor Protocol Number: CIGE025EDE14T Start Date*: 2012-01-12
    Sponsor Name:Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin
    Full Title: A two-center, double blind, placebo-controlled study in parallel design to assess the efficacy and safety of 150 and 300 mg omalizumab in subjects with antihistamine-resistant cold contact urticari...
    Medical condition: Cold contact urticaria
    Disease: Version SOC Term Classification Code Term Level
    15.1 10040785 - Skin and subcutaneous tissue disorders 10009869 Cold urticaria PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2011-003652-39 Sponsor Protocol Number: 30689 Start Date*: 2012-09-17
    Sponsor Name:Karen Schow Jensen
    Full Title: Exercise induced bronchoconstriction in children – a single dose of montelukast as alternative to regular daily doses.
    Medical condition: Exercise induced asthma
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004855 10015649 Exercise induced asthma LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2020-005984-29 Sponsor Protocol Number: NL76248.091.20 Start Date*: 2021-06-28
    Sponsor Name:Radboud University Medical Center
    Full Title: [89Zr]Df-IAB22M2C anti-CD8 minibody PET/CT imaging to assess the in vivo distribution of CD8+ T-cells in COVID-19 patients
    Medical condition: Proven COVID-19.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2018-003199-10 Sponsor Protocol Number: OLE-NLRC4/XIAP.2016.001 Start Date*: Information not available in EudraCT
    Sponsor Name:AB2 Bio Ltd.
    Full Title: Open-label extension study with Tadekinig alfa (r-hIL-18BP) to monitor safety and tolerability in patients with IL-18 driven monogenic autoinflammatory conditions: NLRC4 mutation and XIAP deficiency
    Medical condition: NLRC4 mutation XIAP deficiency
    Disease:
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-004406-26 Sponsor Protocol Number: A/100/0402 Start Date*: 2007-11-26
    Sponsor Name:AVAX Technologies Inc.
    Full Title: Comparison of M-Vax plus Low Dose Interleukin-2 versus Placebo Vaccine plus Low Dose Interleukin-2 in patients with Stage IV Melanoma
    Medical condition: Melanoma Stage IV MedDRA : 10025671
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-004697-25 Sponsor Protocol Number: V528Nov22 Start Date*: 2020-09-14
    Sponsor Name:The Rotunda Hospital
    Full Title: The Home Induction trial: A randomised open-label trial to assess outpatient induction of labour, and compare efficacy of Propess vs Dilapan-S® for induction of labour at 39 weeks’ gestation in nor...
    Medical condition: Normal risk nulliparous women who have no pregnancy-related or medical contraindication to Induction of Labour
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10055563 Labor induction LLT
    Population Age: Adults Gender: Female
    Trial protocol: IE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 09 19:36:52 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA